NEW YORK, NY / ACCESSWIRE / October 18, 2017 / Shares of both Johnson & Johnson and UnitedHealth Group hit new highs in Tuesday trading after reporting third-quarter earnings reports. Both companies also had optimistic outlooks for the future.

RDI Initiates Coverage on:

Johnson & Johnson
http://www.rdinvesting.com/report/?ticker=JNJ

UnitedHealth Group Incorporated
http://www.rdinvesting.com/report/?ticker=UNH

Johnson & Johnson's shares closed up 3.43% yesterday and hit a new high of $141.12 during intra-day trading. Trading volume was more than double compared to average as well after the healthcare giant reported its third-quarter financial report that topped what Wall Street was expecting. The company also raised its outlook that beat analysts' forecasts. For the third quarter, Johnson & Johnson reported sales of $19.7 billion, coming in a lot higher than the $19.28 billion that was expected and an increase from the $17.8 billion in the third quarter a year ago. EPS of $1.90, adjusted for one-time costs, was also higher by a dime as analysts had been expecting $1.80 a share. For the full year, the company is expecting earnings to range from $7.25 to $7.30 per share on revenue of $76.1 billion to $76.5 billion. Wall Street was waiting for $7.18 per share for full-year earnings. Analyst Ashtyn Evans of Edward Jones wrote, "This was a strong quarter for Johnson & Johnson."

Access RDI's Johnson & Johnson Research Report at:
http://www.rdinvesting.com/report/?ticker=JNJ

UnitedHealth Group Incorporated's shares closed up 5.53% on Tuesday with nearly 9 million shares traded. The stock also hit a new all-time high of $206.62 during intra-day trading. The nation's largest health insurer reported a strong third quarter report that had traders excited. For the quarter, the Minnesota-based company reported revenue of $50.32 billion on adjusted EPS of $2.66 per share. Analysts in comparison had expected revenue of $50.35 billion on earnings of $2.56 per share. For its 2017 earnings, the company has forecast $10 per share, which is up from its previous forecast of $9.75 to $9.90 per share. Analysts are expecting $9.86 per share.

Access RDI's UnitedHealth Group Incorporated Research Report at:
http://www.rdinvesting.com/report/?ticker=UNH

Our Actionable Research on Johnson & Johnson (NYSE: JNJ) and UnitedHealth Group Incorporated (NYSE: UNH) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com